Effect of Direct Acting Anti-viral Agents on Insulin Resistance in Chronic HCV Patients

Impact of sustained virologic response on glycemic control among diabetic patients with hepatitis C virus-related liver disease

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

THE EFFECT OF HEPATITIS C VIRUS INFECTION ON INSULIN RESISTANCE IN CHRONIC HEMODIALYSIS PATIENTS

IMPACT OF SUSTAINED VIROLOGICAL RESPONSE OF VIRUS C OUTCOME ON TYPE II DIABETIC PATIENTS INSULIN RESISTANCE AND METABOLIC STATE

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients

INSULIN RESISTANCE IN CHRONIC HEPATITIS C VIRUS PATIENTS RECEIVING DIRECT ACTING ANTIVIRAL DRUGS

OUTCOME OF ERADICATION OF CHRONIC HEPATITIS C VIRUS INFECTION WITH DIRECT ACTING ANTIVIRAL AGENTS ON BLOOD SUGAR CONTROL AND INSULIN RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES ME

IMPACT OF DIABETIC CONTROL ON ACHIEVING SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HCV PATIENTS RECEIVING DIRECT-ACTING ANTIVIRALS

Impact of Treatment of Chronic HCV Patients by Direct Acting Antiviral Drugs (DAADs) on COVID -19 Disease Frequency and Severity